User profiles for Inmaculada C. Sorribes

Inmaculada C. Sorribes

PMx - Integrated Drug Development, Certara Strategic Consulting
Verified email at certara.com
Cited by 112

[HTML][HTML] Minimal barriers to invasion during human colorectal tumor growth

…, T Hardman, LM King, S Tatishchev, IC Sorribes… - Nature …, 2020 - nature.com
Intra-tumoral heterogeneity (ITH) could represent clonal evolution where subclones with
greater fitness confer more malignant phenotypes and invasion constitutes an evolutionary …

[PDF][PDF] A biomechanical model of tumor-induced intracranial pressure and edema in brain tissue

IC Sorribes, MNJ Moore, HM Byrne, HV Jain - Biophysical journal, 2019 - cell.com
Brain tumor growth and tumor-induced edema result in increased intracranial pressure (ICP),
which, in turn, is responsible for conditions as benign as headaches and vomiting or as …

Mitigating temozolomide resistance in glioblastoma via DNA damage-repair inhibition

IC Sorribes, SK Handelman… - Journal of the Royal …, 2020 - royalsocietypublishing.org
Glioblastomas are among the most lethal cancers, with a 5 year survival rate below 25%.
Temozolomide is typically used in glioblastoma treatment; however, the enzymes alkylpurine-…

[HTML][HTML] Standing variations modeling captures inter-individual heterogeneity in a deterministic model of prostate cancer response to combination therapy

HV Jain, IC Sorribes, SK Handelman, J Barnaby… - Cancers, 2021 - mdpi.com
Simple Summary Studying rare outcomes in cancer is challenging because observation of
the rare event may require a very high number of patients or experimental animals. Here, we …

Relating prostate‐specific antigen leakage with vascular tumor growth in a mathematical model of prostate cancer response to androgen deprivation

JP Barnaby, IC Sorribes, HV Jain - Computational and Systems …, 2021 - Wiley Online Library
The use of prostate‐specific antigen (PSA) as a prognostic indicator for prostate cancer (PCa)
patients is controversial, especially since it has been shown to correlate poorly with tumor …

[HTML][HTML] Growth Dynamics of Ductal Carcinoma in Situ Recapitulate Normal Breast Development

MD Ryser, MA Greenwald, IC Sorribes, LM King, A Hall… - bioRxiv, 2023 - ncbi.nlm.nih.gov
Ductal carcinoma in situ (DCIS) and invasive breast cancer share many morphologic, proteomic,
and genomic alterations. Yet in contrast to invasive cancer, many DCIS tumors do not …

Ductal carcinoma in situ is a multiclonal disease

MD Ryser, IC Sorribes, M Greenwald, A Hall, D Mallo… - Cancer Research, 2020 - AACR
Introduction. Ductal carcinoma in situ (DCIS) of the breast has a limited propensity to
progress to invasive breast cancer. However, due to a lack of markers that predict the risk of …

Abstract PR02: Inferring the evolutionary dynamics of ductal carcinoma in situ through multi-regional sequencing and mathematical modeling

MD Ryser, IC Sorribes, M Greenwald, E Wu, A Hall… - Cancer Research, 2020 - AACR
Introduction. The natural history of preinvasive breast cancer, or ductal carcinoma in situ (DCIS)
remains poorly understood. Overcoming this gap would allow risk-appropriate treatment …

[PDF][PDF] Supplemental Information for Mitigating Temozolomide Resistance in Glioblastoma via DNA Damage-Repair Inhibition

IC Sorribes, SK Handelman, HV Jain - rs.figshare.com
The specific dynamics of the model determine structural identifiability, which is considered
to be an analytical property of the model independent of clinical data. In general, a lack of …

Gliomas Diagnosis, Progress, and Treatment: A Mathematical Approach

IC Sorribes Rodriguez - 2019 - diginole.lib.fsu.edu
Inmaculada Concepcion Sorribes Rodriguez defended this dissertation on May 30, 2019.
The members of the supervisory committee were: … Con todo mi corazón, vuestra Inma. …